# The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus

> **NCT06546436** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 12 (estimated)

## Conditions studied

- Autoimmune Type 1 Diabetes Mellitus(T1DM)

## Interventions

- **DRUG:** CARC-101C

## Key facts

- **NCT ID:** NCT06546436
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2025-11-15
- **Final completion:** 2027-05-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546436, "The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*